Skip to content
2000
Volume 16, Issue 8
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Alzheimer’s disease is a devastating and invariably fatal neurodegenerative brain disorder with no cure. AD is characterized by two pathological protein deposits, the senile plaques composed mainly of amyloid-β (Aβ) peptide and the neurofibrillary tangles which are bundles of paired helical filaments (PHF) of protein tau. In addition, oxidative stress, disorders in signal transduction and metal ions dyshomeostasis also play significant roles in the development of AD. A large body of studies suggests that selenium (Se), either as Se-containing compounds or as selenoproteins, may be beneficial in reducing Alzheimer’s pathology. Se is involved in most of the molecular pathways that are important in the progression of AD. We reviewed the literature regarding Se and AD and discussed the roles and mechanisms of Se in AD, as well as the potential of Se in AD prevention.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026615666150827094936
2016-03-01
2025-05-11
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026615666150827094936
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test